A

Arbutus Biopharma Corp
D

ABUS

3.18500
USD
-0.27
(-7.68%)
مغلق
حجم التداول
37,603
الربح لكل سهم
-1
العائد الربحي
-
P/E
-8
حجم السوق
603,531,017
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ADVM
    -0.37000
    (-7.10%)
    4.84000 USD
    ALNY
    ALNY
    -8.630
    (-3.50%)
    237.920 USD
    A
    ARWR
    -1.900
    (-8.54%)
    20.340 USD
    BMY
    BMY
    -0.830
    (-1.44%)
    56.830 USD
    GILD
    GILD
    -2.130
    (-2.30%)
    90.630 USD
    MRNA
    MRNA
    -2.410
    (-5.91%)
    38.350 USD
    REGN
    REGN
    -25.38
    (-3.43%)
    714.50 USD
    V
    VBIV
    0.000000
    (0.00%)
    0.000000 USD
    VRTX
    VRTX
    -21.90
    (-4.67%)
    447.46 USD
    المزيد
الأخبار

العنوان: Arbutus Biopharma Corp

القطاع: Healthcare
الصناعة: Biotechnology
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.